Attagene

What Attagene does

Attagene is a privately held life sciences company founded in 2001, headquartered in Morrisville, North Carolina, and operating with a small team of 11 to 50 employees. The firm is led by Sergei S. Makarov, who serves as President. According to the available firmographic data, Attagene is classified broadly as a "life science company," but the company webpage accessible to the data collector returned only a verification/loading screen with no substantive product, technology, or commercial content. As a result, the company's specific scientific focus (e.g., assays, reagents, instruments, contract research, diagnostics), product portfolio, technology stack, pricing model, go-to-market motion, customer base, funding history, ownership structure, and revenue model are not determinable from the supplied input data.

Given the absence of disclosed products, services, pricing, customers, partnerships, patents, certifications, or funding rounds, the business model cannot be characterized with any specificity. The company profile — small headcount, single named executive, private status, longevity of 25 years, and a one-line "life sciences" descriptor — is consistent with a niche specialty life sciences enterprise, which could range from a research-reagents/tools provider to a contract research organization, a small biotech tool developer, or a consulting/scientific services firm. Investors evaluating Attagene should treat this profile as information-poor: any further due diligence will require direct outreach or alternative data sources to obtain product, revenue, customer, and capital-structure information.

Name

Attagene

Website

https://attagene.com

Company type

Private

Founded year

2001

Headcount range

11–50 employees

Short description

Attagene is a privately held life sciences company founded in 2001, headquartered in Morrisville, North Carolina, operating with 11-50 employees under President Sergei S. Makarov, with no specific products, technology, or customers disclosed in available data.

Ownership category

akta.pro rank

Headquarters

HQ city

Morrisville

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations

Core offering

Attagene is described as a life science company operating in Morrisville, United States, with 11–50 employees and founded in 2001. The source data does not provide any further detail on the company's specific products, services, or technologies, as the firmographic website content was limited to a verification screen with no substantive offering information.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Direct peers

• Cyprotex (Evotec): Specialized ADME-Tox CRO within Evotec offering in vitro toxicology and mechanistic screening — directly competitive with Attagene in delivering predictive toxicology data to pharmaceutical and chemical sponsors.
• SEKISUI XenoTech: Specialized CRO offering in vitro ADME and toxicology services for pharma and chemical clients, closely matching Attagene's pathway-based toxicology assay services in target customer and service format.
• BioIVT: Provider of biospecimens and specialty testing services for pharma R&D, including in vitro pharmacology and toxicology support — closest fit to Attagene's niche of focused life-science testing services for drug development.

Broad incumbents

• Eurofins Scientific: Global CRO platform providing a wide range of safety and toxicology testing services — a large incumbent whose product lines overlap with Attagene's assay-based toxicology work across pharma and consumer chemicals.
• Charles River Laboratories: Major preclinical CRO with extensive discovery and safety assessment services; competes for the same pharma safety-assessment budgets as Attagene but at far greater scale and with broader one-stop-shop capabilities.
• Inotiv: Preclinical CRO offering toxicology, pathology, and research models — directly comparable to Attagene as a buyer of mechanistic toxicology services for regulated industries.
• Thermo Fisher Scientific (Life Sciences / CRO services): Operates life-sciences instruments, reagents, and CRO services spanning toxicology, biosciences, and pharma services — a much larger incumbent that competes with Attagene at scale.

Emerging players

• Promega Corporation: Sells cell-based reporter assay reagents and instruments used in toxicology and pathway analysis — adjacent offering to Attagene's services, with overlapping customer base in pharma screening labs.
• Cell Signaling Technology: Provides antibodies, kits, and reporter assay tools for pathway analysis and toxicology research — partially overlapping with Attagene's pathway-profiling technology stack and customer segments.
• Attana AB: Small-cap Swedish biotech focused on cell-based interaction and affinity assays for drug development — comparable in scale and technology-orientation to Attagene as a niche assay-platform company.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/attagene-inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Attagene